Infectious diseases are the leading causes of morbidity and mortality. Healthcare facilities across the world are at significant risk of cross-contamination, which can lead to hospital-associated infections (HAIs) in patients. The Center for Disease Control and Prevention (CDC) estimates that around four million patients acquire HAI annually, which leads to around 40,000 mortality cases in patients. However, several advancements in surface treating technologies can help reduce patient exposure to harmful microorganisms.

Infectious diseases are the leading causes of morbidity and mortality. Healthcare facilities across the world are at significant risk of cross-contamination, which can lead to hospital-associated infections (HAIs) in patients. The Center for Disease Control and Prevention (CDC) estimates that around four million patients acquire HAI annually, which leads to around 40,000 mortality cases in patients. However, several advancements in surface treating technologies can help reduce patient exposure to harmful microorganisms.

Infectious diseases are the leading causes of morbidity and mortality. Healthcare facilities across the world are at significant risk of cross-contamination, which can lead to hospital-associated infections (HAIs) in patients. The Center for Disease Control and Prevention (CDC) estimates that around four million patients acquire HAI annually, which leads to around 40,000 mortality cases in patients. However, several advancements in surface treating technologies can help reduce patient exposure to harmful microorganisms.